MedPath

A systems biology approach to ocular inflammatio

Conditions
(non-infectious) ocular inflammation, uveitis, age related macular degeneration, inflammatory corneal disease, idiopathic inflammatory orbital disease
Registration Number
NL-OMON22439
Lead Sponsor
niversity Medical Centre Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
440
Inclusion Criteria

18-95 years of age

- diagnosed with non-infectious uveitis (anterior, intermediate, posterior, panuveitis, scleritis) OR

Exclusion Criteria

- (acquired) immune deficiencies

- inadequate knowledge of Dutch

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
We aim to employ an omics-driven systems biology approach on patients with ocular inflammation in order to identify the molecular pathways underlying the pathogenesis of ocular and orbital inflammation and develop clinically usefull markers to predict disease outcome and treatment responses (eg biomarkers). For this we study multiple layers of the immune system (genome, epigenome, proteome, metabolome and cellsubsets).
Secondary Outcome Measures
NameTimeMethod
To identify new therapeutical targets for potential use in future clinical studies by evaluation of novel biomarkers in functional models
© Copyright 2025. All Rights Reserved by MedPath